Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141 SEK | -1.40% | -2.49% | -22.74% |
May. 15 | Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
Sales 2024 * | 939M 89.11M | Sales 2025 * | 1.16B 110M | Capitalization | 7.19B 683M |
---|---|---|---|---|---|
Net income 2024 * | 186M 17.66M | Net income 2025 * | 287M 27.25M | EV / Sales 2024 * | 6.79 x |
Net cash position 2024 * | 818M 77.63M | Net cash position 2025 * | 1.1B 105M | EV / Sales 2025 * | 5.26 x |
P/E ratio 2024 * |
38.8
x | P/E ratio 2025 * |
25
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.33% |
Latest transcript on Surgical Science Sweden AB
1 day | -1.40% | ||
1 week | -2.49% | ||
Current month | -2.49% | ||
1 month | -6.62% | ||
3 months | -4.47% | ||
6 months | -21.40% | ||
Current year | -22.74% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 4 M€ | +15.27% | ||
0.00% | 10 M€ | -3.35% | - | |
0.00% | 145 M€ | -1.49% | - | |
0.00% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 141 | -1.40% | 66,045 |
24-06-05 | 143 | +2.14% | 38,917 |
24-06-04 | 140 | -2.57% | 42,363 |
24-06-03 | 143.7 | -0.62% | 70,656 |
24-05-31 | 144.6 | +1.83% | 151,235 |
Delayed Quote Nasdaq Stockholm, June 07, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.74% | 683M | |
-4.87% | 29.6B | |
+31.35% | 8.65B | |
-28.91% | 2.69B | |
-9.91% | 1.6B | |
-21.02% | 1.36B | |
-35.78% | 1.1B | |
+3.28% | 924M | |
-43.36% | 791M | |
-20.95% | 544M |
- Stock Market
- Equities
- SUS Stock